Medical Biological Defense (Op Sys Dev)
Abstract
The project supports technical upgrades of fielded medical devices and systems, including diagnostic systems and nerve agent treatment systems that contribute to the layered medical defenses against biological and chemical warfare threats facing U.S. Forces on the battlefield. In FY2023, the CBDP RDT&E Projects have been restructured to align to the CBDP portfolio. MB7 efforts in FY2022 progress to the Understand (UN7) portfolio. This restructuring is intended to provide standardization and alignment across CBDP research, development and acquisition efforts. Efforts in this Project include: (1) MODERNIZATION MEDICAL (MOD MED) **Progresses to UN7 in FY2023** The MOD MED program supports improvements to fielded systems and supports post-fielding Food and Drug Administration (FDA) requirements for CBRN medical devices, including FDA-approved autoinjectors and diagnostic equipment, in order to mitigate obsolescence and maintain fielded capabilities. It exploits new and emerging FDA-compliant technologies and updated manufacturing guidelines, supports FDA-required post-marketing commitments (PMCs) and post-marketing requirements (PMRs), and continually mitigates cybersecurity risks. In FY22, MOD MED continued annual cyber security updates and management of hardware and software configurations and addressed efforts to mitigate obsolescence and maintain fielded capabilities. In FY23, MOD MED transitioned to UN7.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2024
- Source ID
- MB7_0607384BP_7_0400_PB_2024
Related Documents
- Root: Chemical and Biological Defense (Operational Systems Development)
- Child Accomplishment: 1) MOD MED - Next Generation Diagnostic System (NGDS) 1
- Child Cost Item: 082d9f4450308c1bc0f37d5d15057a90
- Child Cost Item: e98fe9a5ab26bad68795aebf325e0318
- Child Cost Item: 6ea8a254bbaa0efa73cb382d50b45f7b
- Child Cost Item: 7e8f0b6aa4b50b40bd455775df341d76